Verlauf und Behandlung der Myasthenia gravis in der Schwangerschaft

Armenti V, Radomski JS, Moritz MJ et al (2003) Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 131–141 Barnes PR, Kanabar DJ, Brueton L et al (1995) Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother. Neuromuscul Disord 5:59–65 Batocchi AP, Majolini L, Evoli A et al (1999) Course and treatment of myasthenia gravis during pregnancy. Neurology 52:447–452 Buckley LM, Bullaboy CA, Leichtman L et al (1997) Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40:971–973 Cohen BA, London RS, Goldstein PJ (1976) Myasthenia gravis and preeclampsia. Obstet Gynecol 48:35S–37S Davison JM, Dellagrammatikas H, Parkin JM (1985) Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 92:233–239 Djelmis J, Sostarko M, Mayer D et al (2002) Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 104:21–25 Enns GM, Roeder E, Chan RT et al (1999) Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 86:237–241 Ferrero S, Pretta S, Nicoletti A et al (2005) Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 121:129–138 Fraser D, Turner JW (1953) Myasthenia and pregnancy. Lancet 265:417–419 Gaudier FL, Santiago-Delpin E, Rivera J et al (1988) Pregnancy after renal transplantation. Surg Gynecol Obstet 167:533–543 Gurjar M, Jagia M (2005) Successful management of pregnancy-aggravated myasthenic crisis after complete remission of the disease. Aust N Z J Obstet Gynaecol 45:331–332 Hall JG, Reed SD (1982) Teratogens associated with congenital contractures in humans and in animals. Teratology 25:173–191 Hoff JM, Daltveit AK, Gilhus NE (2003) Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 61:1362–1366 Hoff JM, Daltveit AK, Gilhus NE (2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14:38–43 Jain AB, Venkataramanan R, Fung JJ et al (1997) Pregnancy after liver transplantation under tacrolimus. Transplantation 64:559–565 Jain AB, Reyes J, Marcos A et al (2003) Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center’s experience update at 13 years. Transplantation 76:827–832 Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 160:610–619 Kaynar L, Altuntas F, Aydogdu I et al (2008) Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study. Transfus Apher Sci 38:109–115 Kerr JR (2005) Neonatal effects of breast cancer chemotherapy administered during pregnancy. Pharmacotherapy 25:438–441 Klink DT, Elburg RM van, Schreurs MW et al (2008) Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol. 2008:271363 Lamarque V, Leleu MF, Monka C et al (1997) Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 29:2480 Le Ray C, Coulomb A, Elefant E et al (2004) Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol 103:1091–1094 Lefvert AK, Osterman PO (1983) Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 33:133–138 Licht C, Model P, Kribs A et al (2002) Transiente neonatale Myasthenia gravis. Nervenarzt 73:774–778 Moskovitz DN, BodianC, Chapman ML et al (2004) The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99:656–661 Notarianni LJ, Belk D, Aird SA et al (1995) An in vitro technique for the rapid determination of drug entry into breast milk. Br J Clin Pharmacol 40:333–337 Paladini D, Vassallo M, D’Armiento MR et al (2004) Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. Birth Defects Res A Clin Mol Teratol 70:99–100 Papazian O (1992) Transient neonatal myasthenia gravis. J Child Neurol 7:135–141 Peres RM, Sanseverino MT, Guimaraes JL et al (2001) Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. Braz J Med Biol Res 34:1551–1559 Plauche WC (1991) Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 34:82–99 Polizzi A, Huson SM, Vincent A (2000) Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 62:332–341 Powell HR, Ekert H (1971) Methotrexate-induced congenital malformations. Med J Aust 2:1076–1077 Rodriguez-Pinilla E, Martinez-Frias ML (1998) Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 58:2–5 Ross L (1995) Congenital anomalies in two infants born after gestational gamma-globulin prophylaxis. Acta Paediatr. 84:1436–1437 Schaefer C, Spielmann H, Vetter K (2006) Immunmodulatoren und Therapie rheumatischer Erkrankungen In: Schaefer C, Spielmann H, Vetter K (Hrsg) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban und Fischer, München & Jena S 313–314 Schaefer C, Spielmann H, Vetter K (2006) Immunmodulatoren und Therapie rheumatischer Erkrankungen In: Schaefer C, Spielmann H, Vetter K (Hrsg) Arzneiverordnung in Schwangerschaft und Stillzeit. Urban und Fischer, München Jena, S 679 Schmidt PL, Sims ME, Strassner HT et al (1984) Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 148:178–186 Schroder A, Ellrichmann G, Chehab G et al (2009) Einsatz von Rituximab in der Behandlung neuroimmunologischer Erkrankungen. Nervenarzt 80:155–60 162 Scott JS (1977) Immunological diseases in pregnancy. Prog Allergy 23:321–366 Taylor P (1990) Anticholinesterase agents. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. 8th ed. Pergamon, New York, S 131–149 Vaux KK, Kahole NC, Jones KL (2003) Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway? Birth Defects Res A Clin Mol Teratol 67:403–408 Vincent A, Newland C, Brueton L et al (1995) Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346:24–25